Aug 13 2010
Medtronic, Inc. (NYSE: MDT) today announced it has completed its acquisition of ATS Medical, Inc. following payment of $4.00 per share in cash for each share of ATS Medical stock and assumption of net debt, with a total transaction value of approximately $370 million.
“Our completed purchase of ATS Medical immediately expands Medtronic's product offerings and pipeline of surgical valves, repair products and surgical ablation technologies.”
"Medtronic is focused on providing innovative solutions for cardiac surgeons and their patients worldwide," said John Liddicoat, M.D., vice president and general manager of the Structural Heart business at Medtronic. "Our completed purchase of ATS Medical immediately expands Medtronic's product offerings and pipeline of surgical valves, repair products and surgical ablation technologies."
Medtronic is committed to advancing the treatment of structural heart disease through collaboration with leading clinicians, researchers and scientists worldwide.
SOURCE Medtronic, Inc.
Tailored vitamin D regimens offer significant cardiac benefit